Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Schering-Plough Drops Garenoxacin NDA, But Leaves Door Open For Resubmission

Aug 21 2006

• By The Pink Sheet Daily

Related Content

Schering’s Antibiotic Garenoxacin Gets Advisory Committee Date

Jul 24 2006

Schering-Plough Licensing Toyama Antibiotic Garenoxacin, Picking Up Where Bristol Left Off

Mar 31 2004

Phase III Antibiotic Garenoxacin Will Be Out-Licensed, Schering Says

Apr 21 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window